Different Reversal Agents in Pediatric Day-case Cancer Surgery

• Status: Unknown status
• Trial end date: 2019-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study was to compare the efficacy of sugammadex and neostigmine on

reversing neuromuscular blockers in pediatric patients undergoing outpatient surgical

procedures.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Cancer Institute, Egypt
• Treatments: Neostigmine; Neuromuscular Blocking Agents

Criteria

Inclusion Criteria:

• Age ≥2 years and < 18 years.

• American society of anesthesiologists (ASA) status 1-3.

• patients undergoing outpatient procedures

Exclusion Criteria:

• Known drug hypersensitivity.-

• History of renal or hepatic failure.

• Diseases of the neuromuscular junction.

• history of malignant hyperthermia.